Literature DB >> 18539714

Catastrophic antiphospholipid syndrome mimicking a malignant pancreatic tumour--a case report.

S van Wissen1, B A J Bastiaansen, A K Stroobants, E J van den Dool, M M Idu, M Levi, E S G Stroes.   

Abstract

The catastrophic antiphospholipid syndrome is characterised by rapid onset thromboses, often resistant to conventional anticoagulant treatment, and resulting in life threatening multiple organ dysfunction. The diagnosis of catastrophic antiphospholipid syndrome may be difficult, predominantly due to its frequently atypical presentation. We report a case of a 35-year-old female who presented with a pancreatic tumour and extensive thromboses. Following a storm of ischemic events due to thrombotic occlusions in spite of therapeutic heparin dose, the suspicion of catastrophic antiphospholipid syndrome emerged. The patient was successfully treated with anticoagulants, immunoglobulins, plasmapheresis and rituximab. The present report shows that the use of the diluted Russell's viper venom time can be helpful in providing additional information on the lupus anticoagulants antibody status, allowing careful monitoring of lupus anticoagulants conversion and hence response to therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18539714     DOI: 10.1177/0961203307087406

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  4 in total

1.  Top 10 clinical research developments in antiphospholipid syndrome.

Authors:  Medha Barbhaiya; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

Review 2.  Use of rituximab in the antiphospholipid syndrome.

Authors:  Deepak Kumar; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

3.  Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.

Authors:  Yolanda Braun-Moscovici; Yonatan Butbul-Aviel; Ludmila Guralnik; Kochava Toledano; Doron Markovits; Alexander Rozin; Menahem A Nahir; Alexandra Balbir-Gurman
Journal:  Rheumatol Int       Date:  2012-12-14       Impact factor: 3.580

4.  Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report.

Authors:  Tadashi Sofue; Yushi Hayashida; Taiga Hara; Kazuyo Kawakami; Nobufumi Ueda; Yoshio Kushida; Masashi Inui; Hiroaki Dobashi; Yoshiyuki Kakehi; Masakazu Kohno
Journal:  BMC Nephrol       Date:  2014-10-15       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.